Regarding the evidence-based use of micronized progesterone
An issue of habitual miscarriage poses a high social importance especially during COVID-19 pandemic. Meanwhile, healthcareworkers faced a mass media campaign against using micronized progesterone upon habitual miscarriage, which, as viewed by us, displays signs of prejudiced data manipulation and ma...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2020-09-01
|
Series: | Акушерство, гинекология и репродукция |
Subjects: | |
Online Access: | https://www.gynecology.su/jour/article/view/783 |
id |
doaj-1e859396d53242488c1e30b1c61ba799 |
---|---|
record_format |
Article |
spelling |
doaj-1e859396d53242488c1e30b1c61ba7992021-07-28T13:44:42ZrusIRBIS LLCАкушерство, гинекология и репродукция2313-73472500-31942020-09-0114337438310.17749/2313-7347/ob.gyn.rep.2020.171571Regarding the evidence-based use of micronized progesteroneA. D. Makatsariya0G. C. Di Renzo1G. Rizzo2V. O. Bitsadze3J. Kh. Khizroeva4D. V. Blinov5E. I. Vovk6I. E. Govorov7D. L. Guryev8G. B. Dikke9M. S. Zainulina10N. S. Zakharova11V. V. Kovalev12E. V. Komlichenko13V. A. Kramarskiy14A. B. Loginov15L. I. Maltseva16V. B. Nemirovskiy17D. A. Ponomarev18E. B. Rudakova19N. V. Samburova20O. F. Serova21F. K. Tetelyutina22M. V. Tretyakova23J. Yu. Ungiadze24V. I. Tsibizova25Sechenov UniversitySechenov University; Center for Prenatal and Reproductive Medicine, University of PerugiaTor Vergata University of RomeSechenov UniversitySechenov UniversityInstitute for Preventive and Social Medicine; Lapino Clinic Hospital, MD Medical Group; Moscow Haass Medical - Social InstituteMoscow State University of Medicine and Dentistry named after А. I. Evdokimov, Health Ministry of Russian FederationAlmazov National Medical Research Centre, Health Ministry of Russian FederationYaroslavl State Medical University, Health Ministry of Russian Federation; Yaroslavl Regional Perinatal CenterAcademy of Medical Education named by F. I. InozemtsevI.P. Pavlov First Saint Petersburg State Medical University, Health Ministry of Russian Federation; V.F. Snegirev Maternity Hospital № 6 and City Obstetric Hematological CenterCity Clinical Hospital named after V. V. Vinogradov, Moscow Healthcare DepartmentUral State Medical University, Health Ministry of Russian FederationAlmazov National Medical Research Centre, Health Ministry of Russian FederationIrkutsk State Medical Academy of Postgraduate Education - Branch Campus of Russian Medical Academy of Continuing Professional Education, Health Ministry of Russian FederationV.F. Snegirev Maternity Hospital № 6 and City Obstetric Hematological CenterKazan State Medical Academy - Branch of Russian Medical Academy of Continuing Professional Education, Health Ministry of Russian FederationMaternity Hospital № 1 - Branch of City Clinical Hospital № 67 named after L. A. Vorokhobov, Moscow Healthcare DepartmentMaternity Hospital № 4 - Branch of City Clinical Hospital named after V. V. Vinogradov, Moscow Healthcare DepartmentState Scientific Center of the Russian Federation - Federal Medical Biophysical Center named after A. I. Burnazyan, Federal Medical and Biological Agency of RussiaSechenov UniversityMoscow Regional Perinatal CenterIzhevsk State Medical Academy, Health Ministry of Russian Federation«Medical Center» LLCShota Rustaveli Batumi State University; Iris Borchashvili Health Center MedinaAlmazov National Medical Research Centre, Health Ministry of Russian FederationAn issue of habitual miscarriage poses a high social importance especially during COVID-19 pandemic. Meanwhile, healthcareworkers faced a mass media campaign against using micronized progesterone upon habitual miscarriage, which, as viewed by us, displays signs of prejudiced data manipulation and may disorient practitioners. In this Letter we provide objective information on accumulated data regarding gestagenes efficacy and safety. We invoke healthcare professionals to make decisions deserving independent primary source trust presented by original scientific papers published in peer-reviewed journals, clinical recommendations proposed by professional medical communities as well as treatment standards and protocols.https://www.gynecology.su/jour/article/view/783gestagenesprogesteronedidrogesteronehabitual miscarriageevidence base |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
A. D. Makatsariya G. C. Di Renzo G. Rizzo V. O. Bitsadze J. Kh. Khizroeva D. V. Blinov E. I. Vovk I. E. Govorov D. L. Guryev G. B. Dikke M. S. Zainulina N. S. Zakharova V. V. Kovalev E. V. Komlichenko V. A. Kramarskiy A. B. Loginov L. I. Maltseva V. B. Nemirovskiy D. A. Ponomarev E. B. Rudakova N. V. Samburova O. F. Serova F. K. Tetelyutina M. V. Tretyakova J. Yu. Ungiadze V. I. Tsibizova |
spellingShingle |
A. D. Makatsariya G. C. Di Renzo G. Rizzo V. O. Bitsadze J. Kh. Khizroeva D. V. Blinov E. I. Vovk I. E. Govorov D. L. Guryev G. B. Dikke M. S. Zainulina N. S. Zakharova V. V. Kovalev E. V. Komlichenko V. A. Kramarskiy A. B. Loginov L. I. Maltseva V. B. Nemirovskiy D. A. Ponomarev E. B. Rudakova N. V. Samburova O. F. Serova F. K. Tetelyutina M. V. Tretyakova J. Yu. Ungiadze V. I. Tsibizova Regarding the evidence-based use of micronized progesterone Акушерство, гинекология и репродукция gestagenes progesterone didrogesterone habitual miscarriage evidence base |
author_facet |
A. D. Makatsariya G. C. Di Renzo G. Rizzo V. O. Bitsadze J. Kh. Khizroeva D. V. Blinov E. I. Vovk I. E. Govorov D. L. Guryev G. B. Dikke M. S. Zainulina N. S. Zakharova V. V. Kovalev E. V. Komlichenko V. A. Kramarskiy A. B. Loginov L. I. Maltseva V. B. Nemirovskiy D. A. Ponomarev E. B. Rudakova N. V. Samburova O. F. Serova F. K. Tetelyutina M. V. Tretyakova J. Yu. Ungiadze V. I. Tsibizova |
author_sort |
A. D. Makatsariya |
title |
Regarding the evidence-based use of micronized progesterone |
title_short |
Regarding the evidence-based use of micronized progesterone |
title_full |
Regarding the evidence-based use of micronized progesterone |
title_fullStr |
Regarding the evidence-based use of micronized progesterone |
title_full_unstemmed |
Regarding the evidence-based use of micronized progesterone |
title_sort |
regarding the evidence-based use of micronized progesterone |
publisher |
IRBIS LLC |
series |
Акушерство, гинекология и репродукция |
issn |
2313-7347 2500-3194 |
publishDate |
2020-09-01 |
description |
An issue of habitual miscarriage poses a high social importance especially during COVID-19 pandemic. Meanwhile, healthcareworkers faced a mass media campaign against using micronized progesterone upon habitual miscarriage, which, as viewed by us, displays signs of prejudiced data manipulation and may disorient practitioners. In this Letter we provide objective information on accumulated data regarding gestagenes efficacy and safety. We invoke healthcare professionals to make decisions deserving independent primary source trust presented by original scientific papers published in peer-reviewed journals, clinical recommendations proposed by professional medical communities as well as treatment standards and protocols. |
topic |
gestagenes progesterone didrogesterone habitual miscarriage evidence base |
url |
https://www.gynecology.su/jour/article/view/783 |
work_keys_str_mv |
AT admakatsariya regardingtheevidencebaseduseofmicronizedprogesterone AT gcdirenzo regardingtheevidencebaseduseofmicronizedprogesterone AT grizzo regardingtheevidencebaseduseofmicronizedprogesterone AT vobitsadze regardingtheevidencebaseduseofmicronizedprogesterone AT jkhkhizroeva regardingtheevidencebaseduseofmicronizedprogesterone AT dvblinov regardingtheevidencebaseduseofmicronizedprogesterone AT eivovk regardingtheevidencebaseduseofmicronizedprogesterone AT iegovorov regardingtheevidencebaseduseofmicronizedprogesterone AT dlguryev regardingtheevidencebaseduseofmicronizedprogesterone AT gbdikke regardingtheevidencebaseduseofmicronizedprogesterone AT mszainulina regardingtheevidencebaseduseofmicronizedprogesterone AT nszakharova regardingtheevidencebaseduseofmicronizedprogesterone AT vvkovalev regardingtheevidencebaseduseofmicronizedprogesterone AT evkomlichenko regardingtheevidencebaseduseofmicronizedprogesterone AT vakramarskiy regardingtheevidencebaseduseofmicronizedprogesterone AT abloginov regardingtheevidencebaseduseofmicronizedprogesterone AT limaltseva regardingtheevidencebaseduseofmicronizedprogesterone AT vbnemirovskiy regardingtheevidencebaseduseofmicronizedprogesterone AT daponomarev regardingtheevidencebaseduseofmicronizedprogesterone AT ebrudakova regardingtheevidencebaseduseofmicronizedprogesterone AT nvsamburova regardingtheevidencebaseduseofmicronizedprogesterone AT ofserova regardingtheevidencebaseduseofmicronizedprogesterone AT fktetelyutina regardingtheevidencebaseduseofmicronizedprogesterone AT mvtretyakova regardingtheevidencebaseduseofmicronizedprogesterone AT jyuungiadze regardingtheevidencebaseduseofmicronizedprogesterone AT vitsibizova regardingtheevidencebaseduseofmicronizedprogesterone |
_version_ |
1721271967280005120 |